Cargando…
Repurposing old drugs as antiviral agents for coronaviruses
BACKGROUND: New therapeutic options to address the ongoing coronavirus disease 2019 (COVID-19) pandemic are urgently needed. One possible strategy is the repurposing of existing drugs approved for other indications as antiviral agents for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)....
Autores principales: | Yang, Cheng-Wei, Peng, Tzu-Ting, Hsu, Hsing-Yu, Lee, Yue-Zhi, Wu, Szu-Huei, Lin, Wen-Hsing, Ke, Yi-Yu, Hsu, Tsu-An, Yeh, Teng-Kuang, Huang, Wen-Zheng, Lin, Jiunn-Horng, Sytwu, Huey-Kang, Chen, Chiung-Tong, Lee, Shiow-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245249/ https://www.ncbi.nlm.nih.gov/pubmed/32563698 http://dx.doi.org/10.1016/j.bj.2020.05.003 |
Ejemplares similares
-
Artificial intelligence approach fighting COVID-19 with repurposing drugs
por: Ke, Yi-Yu, et al.
Publicado: (2020) -
Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives
por: Yang, Cheng-Wei, et al.
Publicado: (2020) -
Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
por: Hsu, Hsing-Yu, et al.
Publicado: (2021) -
Development
of Furanopyrimidine-Based Orally Active
Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell
Lung Cancer
por: Li, Mu-Chun, et al.
Publicado: (2023) -
Colloidal Assemblies Composed of Polymeric Micellar/Emulsified Systems Integrate Cancer Therapy Combining a Tumor-Associated Antigen Vaccine and Chemotherapeutic Regimens
por: Huang, Chiung-Yi, et al.
Publicado: (2021)